The Question Is Whether To Buy Or Not To Buy Universal Technical Institute Inc (NYSE: UTI)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Universal Technical Institute Inc is listed on the NYSE as a member of the Consumer Defensive sector and is a part of the Education & Training Services industry. The current market capitalization of Universal Technical Institute Inc is $1.47B. A total of 0.82 million shares were traded on the day, compared to an average of 587.25K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, UTI has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

In the most recent transaction, Brochick George W. sold 8,000 shares of UTI for 27.59 per share on Feb 26 ’25. After the transaction, the Director now owns 34,917 company shares. In a previous transaction on Feb 26 ’25, Brochick George W. bought 8,000 shares at 27.15 per share.

Among the insiders who sold shares, Coliseum Capital Management, L disposed of 704,881 shares on Feb 10 ’25 at a per-share price of $28.20. This resulted in the Director holding 6,145,755 shares of UTI after the transaction. In another insider transaction, Coliseum Capital Management, L sold 2,483,579 shares at $25.10 per share on Dec 02 ’24. Company shares held by the Director now total 6,850,636.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for UTI in the last 3 months, the mean price target is $33.60 with high estimates of $36.00 and low estimates of $31.00. In terms of 52-week highs and lows, UTI has a high of $30.56 and a low of $13.66.

As of this writing, UTI has an earnings estimate of $0 per share for the current quarter.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. UTI’s latest balance sheet shows that the firm has $133.72M in Cash & Short Term Investments as of fiscal 2021. There were $198.03M in debt and $132.72M in liabilities at the time. Its Book Value Per Share was $5.15, while its Total Shareholder’s Equity was $188.53M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTI is Buy with a score of 5.00.

Most Popular

Related Posts